Programmed death-1 or programmed death ligand-1 inhibitors? A meta-analysis of differential efficacy as compared to chemotherapy in advanced non-small cell lung cancer

医学 肺癌 化疗 程序性细胞死亡 程序性细胞死亡1 荟萃分析 肿瘤科 癌症 细胞凋亡 内科学 PD-L1 免疫疗法 生物化学 化学
作者
Hakan Bozcuk,Mehmet Artaç,Hasan Mutlu,Özlem Nuray Sever,Mustafa Yıldırım
出处
期刊:Journal of Oncology Pharmacy Practice [SAGE Publishing]
卷期号:27 (2): 405-413 被引量:3
标识
DOI:10.1177/1078155220964903
摘要

Background Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PDL-1) inhibitors have improved survival over chemotherapy in advanced Non- Small Cell Lung Cancer (NSCLC). However, it is unclear if there are class specific differences in the efficacy of Checkpoint Inhibitors (CPIs) in NSCLC, and this paper is designed to answer these clinical questions. Methods For this Meta-analysis, we searched PubMed, Science of Web, “Clinicaltrials.gov” and online sources for trials comparing PD-1 and PDL-1 CPIs in advanced NSCLC. The data for Hazard Ratio (HR) and their Confidence Intervals (CI) for Overall Survival (OS) was extracted. Results A sum of 9739 patients from 16 trials were included in the efficacy evaluation. For the OS endpoint, both PD-1 inhibitors (HR = 0.76, 95%CI = 0.69–0.83, P < 0.001) and PDL-1 inhibitors (HR = 0.84, 95%CI = 0.74–0.95, P < 0.001) were superior to chemotherapy in treatment naïve (upfront) patients, the results were similar in treatment refractory patients (PD-1 inhibitors (HR = 0.67, 95%CI = 0.60–0.75, P < 0.001) and PDL-1 inhibitors (HR = 0.78, 95%CI = 0.69–0.88, P < 0.001) were superior to chemotherapy). There was no difference in the effect of PD-1 and PDL-1 classes of CPIs over chemotherapy in treatment naïve and treatment refractory settings (Q = 1.88, df = 1, P = 0.017, and, Q = 3.27, df = 1, P = 0.070, respectively). Conclusion Efficacy of PD-1 and PDL-1 class of CPIs was not different, although differences among individual CPIs or their combinations cannot be excluded. We were also able to compute pooled efficacy data, as compared to chemotherapy alone, for trials where these groups of CPIs were utilized.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
深情安青应助TOBET采纳,获得10
刚刚
英俊的铭应助飘零枫叶采纳,获得10
1秒前
迷路向松发布了新的文献求助10
1秒前
1秒前
领导范儿应助北栀采纳,获得10
1秒前
1秒前
小蘑菇应助激昂的南烟采纳,获得10
1秒前
DiJia完成签到 ,获得积分10
1秒前
xzleee完成签到 ,获得积分10
1秒前
ATM完成签到,获得积分20
2秒前
求助123完成签到,获得积分10
2秒前
2秒前
2秒前
2秒前
2秒前
CodeCraft应助tdtk采纳,获得10
2秒前
风中的电脑完成签到,获得积分10
3秒前
王丽芳发布了新的文献求助10
3秒前
你66发布了新的文献求助10
3秒前
ATM发布了新的文献求助10
4秒前
小小怪完成签到,获得积分20
4秒前
科目三应助小汤采纳,获得10
4秒前
德爱完成签到,获得积分10
4秒前
可爱的函函应助mmRadio采纳,获得10
4秒前
科研通AI2S应助张小哥12采纳,获得10
5秒前
5秒前
5秒前
snitch完成签到,获得积分10
6秒前
6秒前
6秒前
tong完成签到,获得积分10
6秒前
黯然发布了新的文献求助10
6秒前
WWJ发布了新的文献求助10
6秒前
Luo发布了新的文献求助10
7秒前
琪七发布了新的文献求助10
7秒前
德爱发布了新的文献求助10
7秒前
8秒前
8秒前
贾千兰发布了新的文献求助10
8秒前
贰鸟应助一吃一大碗采纳,获得10
9秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3970632
求助须知:如何正确求助?哪些是违规求助? 3515261
关于积分的说明 11177794
捐赠科研通 3250448
什么是DOI,文献DOI怎么找? 1795314
邀请新用户注册赠送积分活动 875781
科研通“疑难数据库(出版商)”最低求助积分说明 805073